Bing

Shares of Good Times Restaurants Inc. increased by 34.98 percent Friday — a gain unmatched by any other Colorado stock. GTIM ended up 71 cents and ... Allos Therapeutics Inc. (ALTH): down 0.56 percent, or a penny, to $1.78.
The Business Journal · 6/15/2012
Allos Therapeutics (NASDAQ:ALTH) saw its stock price sink over twelve percent on Friday, after announcing that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) issued a poor opinion on the approval of …
Proactiveinvestors · 1/20/2012
S&P and J.P. Morgan upgraded the stock. Qualcomm gained 10%. Allos Therapeutics (ALTH) surged 12% -- on heavy volume -- after submitting the last component of its new drug application to the Food and Drug Administration for approval to market …
Bloomberg · 12/3/2003
--(Business Wire)-- Allos Therapeutics, Inc. (Nasdaq: ALTH) announced today the closing of its previously announced underwritten public offering of 12,420,000 shares of newly issued common stock at a public offering price of $5.64 per share. The number of ...
Reuters · 5/29/2008
NEW YORK (MarketWatch) -- Allos Therapeutics Inc. ALTH said Tuesday it filed a universal shelf registration with the Securities and Exchange Commission to sell up to $100 million of common stock, preferred stock, depository shares, debt securities and ...
Market Watch · 6/13/2006
Sign Up for our Free Stock Newsletter. Stout is also on the boards at Allos Therapeutics Inc. (NASDAQ: ALTH), Jabil Circuit Inc. (NYSE: JBL) and Airgas Inc. (NYSE: ARG). Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your …
TransWorldNews · 11/3/2009
The stock was up another 14 percent on Tuesday as others jumped ... Amicus Therapeutics Inc(FOLD.O), Hana Biosciences Inc HNAB.O and Allos Therapeutics Inc ALTH.O as potential small biotech basket options. Becker said he does not have any long …
Reuters · ByBill Berkrot · 7/21/2009
Amag Pharmaceuticals CEO Brian Pereira recently told Xconomy he was shopping for acquisitions to ... vow by announcing it would merge with Allos Therapeutics (NASDAQ: ALTH) in an all-stock deal worth $686 million. Allos, based in Westminster, CO …
Xconomy · ByArlene Weintraub · 7/20/2011
The stocks are driven by very specific events that can make them ... current standard of care against the current standard of care alone. Allos Therapeutics (ALTH) will be announcing results of a mid-stage study of its blood cancer drug Folotyn for the ...
Minyanville · 3/18/2010
When it comes time to scrub off what is invariably too much speed, the Alth rotors and Vesrah pads proved to be a great combination. Overall braking power is considerably stronger than stock, with better initial bite and progression, even though the pad ...
Sport Rider · 6/29/2010